↓ Skip to main content

Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study

Overview of attention for article published in Lipids in Health and Disease, January 2009
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
Published in
Lipids in Health and Disease, January 2009
DOI 10.1186/1476-511x-8-2
Pubmed ID
Authors

Jeremy Koppel, Heather Bradshaw, Terry E Goldberg, Houman Khalili, Philippe Marambaud, Michael J Walker, Miguel Pazos, Marc L Gordon, Erica Christen, Peter Davies

Abstract

Neuropathological, animal, and cell culture studies point to a role for the body's own endogenous cannabinoids (eCBs) system in Alzheimer's disease (AD) pathology and treatment. To date, no published studies have investigated the potential utility of circulating eCBs as diagnostic biomarkers for AD or the impact of central eCBs on cognition.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 3%
United States 2 3%
India 1 1%
Spain 1 1%
Unknown 62 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 22%
Student > Ph. D. Student 11 16%
Student > Bachelor 10 15%
Student > Master 10 15%
Student > Doctoral Student 4 6%
Other 8 12%
Unknown 10 15%
Readers by discipline Count As %
Medicine and Dentistry 13 19%
Agricultural and Biological Sciences 12 18%
Neuroscience 10 15%
Psychology 4 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 10 15%
Unknown 16 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2015.
All research outputs
#9,976,920
of 12,463,059 outputs
Outputs from Lipids in Health and Disease
#596
of 898 outputs
Outputs of similar age
#153,949
of 220,685 outputs
Outputs of similar age from Lipids in Health and Disease
#1
of 1 outputs
Altmetric has tracked 12,463,059 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 898 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 220,685 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them